Showing papers on "Addiction medicine published in 1998"

Abuse Potential of Dronabinol (Marinol

Abstract: Dronabinol is an oral form of delta-9-tetrahydrocannabinol indicated for treatment of anorexia associated with weight loss in individuals with AIDS, and nausea and vomiting associated with cancer chemotherapy. The authors reviewed the literature and conducted surveys and interviews among addiction medicine specialists, oncologists, researchers in cancer and HIV treatment, and law enforcement personnel to determine the abuse liability of dronabinol. There is no evidence of abuse or diversion of dronabinol. Available prescription tracking data indicates that use remains within the therapeutic dosage range over time. Healthcare professionals have detected no indication of "scrip-chasing" or "doctor-shopping" among the patients for whom they have prescribed dronabinol. Cannabis-dependent populations, such as those treated in our Clinic and seen by the addiction medicine specialists we interviewed, have demonstrated no interest in abuse of dronabinol. There is no street market for dronabinol, and no evidence of any diversion of dronabinol for sale as a street drug. Furthermore, dronabinol does not provide effects that are considered desirable in a drug of abuse. The onset of action is slow and gradual, it is at most only weakly reinforcing, and the overwhelming majority of reports of users indicate that its effects are dysphoric and unappealing. This profile of effects gives dronabinol a very low abuse potential.

Learning the Language of Addiction Counseling

Abstract: Drawing from her years of experience working in the addiction-counseling field, Geri Miller provides a balanced overview of the major theoretical underpinnings and clinical practices in the field, covering all of the essentials--from assessment and diagnosis of addiction to preparing for certification and licensure as an addiction professional. Contents: 1. Introduction 2. Theories of counselling related to addiction treatment 3. Assessment and diagnosis of addiction 4. Assessment, diagnosis, and treatment of co-occurring disorders. 5. The treatment process for addictions 6. Treatment-related issues 7. Relapse prevention 8. Self-help groups 9. Current and evolving therapy approaches and techniques 10. Culturally sensitive addiction counselling 11. Incorporating spirituality and addiction counselling 12. Chronic pain assessment, treatment and aftercare 13. Personal and professional development of the counsellor 14. Preparing for certification and licensure as an addiction professional

Marijuana use prevention: the In-DEPTH model program.

Abstract: Over the past five years marijuana use has doubled among eighth, 10th and 12th grade students, and in several demographics it has tripled. The recent debate over the legalization of medical marijuana (California's Proposition 215), positive media messages, lack of parent/child discussion, and denial by schools and communities may be contributing factors to the rise of drug use among adolescents. The In-DEPTH program, a unique drug education model that educates, prevents, and provides intervention strategies in adolescent marijuana use, has in small multisite surveys shown initial success in decreasing marijuana use and positively changing beliefs. The program is based on pharmacology, addiction medicine principles, economics and the pharmaceutical sales model, and examines drug dealing as well as drug use.

Teaching on addiction issues lacking in medical school, specialists told

Abstract: During the 1997 annual scientific meeting of the Canadian Society of Addiction Medicine, a medical student complained that medical schools do not provide enough education on addiction-related issues. April Boyd said most students want the information because they think they will face these issues when they enter practice.

Review: Benzodiazepines are more effective than neuroleptics in reducing delirium and seizures in alcohol withdrawal

Abstract: Source Citation Mayo-Smith MF, for the American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. Pharmacological management of alcohol withdrawal. A ...

Addiction medicine perspective on the medicalization of marijuana.

Abstract: Many medical, ethical, legal and political issues have been raised by legislation in California removing criminal penalties for the medical use of marijuana. The California Society of Addiction Medicine (CSAM) has taken an addiction medicine perspective on the use of marijuana as medicine in an effort to create a neutral framework for dealing with these issues. As part of this perspective, CSAM has called for marijuana to be rescheduled beneath its current Schedule I status. Guidelines for safely integrating cannabis into accepted medical practices are suggested.

Anxiety of physicians about addiction therapy

Abstract: An analysis of reasons why many physicians show considerable reservations towards sufficient diagnostic and treatment measures of alcohol-related disorders produced several factors: (a) guilt and aggression are linked to addictive disorders in an unproportional way, exceeding the common disease concept; (b) defense mechanisms on the part of the physician as well as the patient impair the therapeutic relationship. (c) Motivation and treatment of alcoholic patients could be improved by offering Balint groups, therapeutic supervision and intensified training of physicians.

Review: benzodiazepines are more effective than neuroleptics in reducing delirium and seizures in alcohol withdrawal

Abstract: Source Citation Mayo-Smith MF, for the American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. Pharmacological management of alcohol withdrawal. A ...